Skip to main content
Clinical Trials/IRCT2015021821134N1
IRCT2015021821134N1
Completed
Phase 2

Assessing the effect of progressive muscle relaxation on glycosylated hemoglobin and health- related quality of life in patients with type 2 diabetes

Vice chancellor for research, Iran university of medical science0 sites100 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Type2 diabetes.
Sponsor
Vice chancellor for research, Iran university of medical science
Enrollment
100
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice chancellor for research, Iran university of medical science

Eligibility Criteria

Inclusion Criteria

  • Age between 35 to 65 years; Literacy; A definitive diagnosis of type 2 diabetes by a physician; Oral anti\-diabetic medication for at least 1 year; No risk of cardiovascular disease, thyroid disease, intermittent claudication, cerebrovascular accidents, arthritis, diabetic retinopathy, chronic renal failure, chronic pulmonary disease, diabetic foot, severe vision or hearing impairment; Lack of mental illnesses and psychiatric drugs; The absence of sensory perception and communication problems; The absence of limb movement disorders and muscle injury; Not Hype; Lack of relaxation training

Exclusion Criteria

  • The absence of one of the training sessions for the intervention group; Performance progressive muscle relaxation in the house less than 10 sessions per week (record in the self\-report check lists); Drug regime change during the 12\-week study (in both control and intervention); The use of other complementary therapies during the study; Lack of learning and skill acquisition procedure; Acute complications of diabetes (such as ketoacidosis and hypoglycemia)

Outcomes

Primary Outcomes

Not specified

Similar Trials